KONTINUIraNa MEdICINsKa EdUKaCIja Potencijal primene matičnih ćelija kod lečenja kardiovaskularnih bolesti i kongenitalnih anomalija

Amira Fazlagic ,
Amira Fazlagic
Miroslava Gojnic
Miroslava Gojnic

Published: 01.12.2010.

Biochemistry

Volume 27, Issue 1 (2011)

pp. 267-269;

https://doi.org/10.5937/matmed1101267f

Abstract

Keywords

References

1.
2010;(2):183–92.
2.
Umbilical cord blood stem cells--an ethical source for regenerative medicine. Forraz N; Med Law. 2008;(1):147–65.
3.
Mcguckin C, Forraz N, Baradez M, Basford C, Dickinson A. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. acta Neurobiol Exp (Wars). 2006;(4):321–9.
4.
Gluckman E, Ha B, Hs F, Douglas G, Esperou H, Thierry G, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLaidentical sibling. N Engl j Med. 1989;(17):1174–8.
5.
1991;7–8.
6.
Weber B, Emmert M, Gruenenfelder, Verbeek R, Bracher M, Black M, et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a onestep intervention in primates. 2011;
7.
Cummings I, Kelm G, Emmert M, Weber B, Zünd G, Sp H. Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases. autor za korespondenciju: Prof.dr sci.med amira Fazlagić e-mail: mimaf@eunet.rs Karađorđeva. 2011;

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners